BMY
Bristol-Myers Squibb CompanyHealthcare$59.60
▲ Bullish
Mkt Cap: $121.69B|Float: 2.03B|SI: 1.5%|DTC: 2.5
Data as of market close Apr 2, 2026
IV Rank
80
IV Pctl
67%
HV 20d
20.2%
52W Range
$42-$63
ATR(14)
$1.32
Exp. Move
±3.1%
P/C Ratio
0.88
Earnings
Apr 30
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Moderate
BMY Key Options Data
- IV Rank
- 80.2%
- Total GEX
- $0.02B
- Total DEX
- $15.6M
- Max Pain
- $59.00
- Expected Move
- ±3.1%
- Put/Call OI
- 0.88
- Net Premium
- $2.9M
- Spot Price
- $59.60
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$1.83 | ±3.1% | $57.77 | $61.43 |
| 2026-04-17 | 15 | ±$2.62 | ±4.4% | $56.98 | $62.22 |
| 2026-04-24 | 22 | ±$3.17 | ±5.3% | $56.43 | $62.76 |
| 2026-05-01 | 29 | ±$4.37 | ±7.3% | $55.23 | $63.97 |
| 2026-05-08 | 36 | ±$2.15 | ±3.6% | $57.45 | $61.75 |
| 2026-05-15 | 43 | ±$5.06 | ±8.5% | $54.53 | $64.66 |
Explore BMY options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.